WASHINGTON, July 31 (Reuters) - President Donald Trump signed and sent letters to the CEOs of 17 pharmaceutical companies, urging action to address the high cost of prescription drugs for Americans, the White House said on Thursday.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.